Pulmonary pleomorphic carcinoma with few PD-1-positive immune cells and regulatory T cells that showed a complete response to nivolumab.

about

Presence of few PD-1-expressing tumor-infiltrating immune cells is a potential predictor of improved response to salvage chemotherapy following nivolumab for non-small cell lung cancer: An exploratory case series

P2860

Q58732728-8E107467-F08D-420B-A1B0-806E2F9D4459

P2860

Pulmonary pleomorphic carcinoma with few PD-1-positive immune cells and regulatory T cells that showed a complete response to nivolumab.

Item

http://www.wikidata.org/entity/Q47713714

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pulmonary pleomorphic carcinom ...... omplete response to nivolumab.

@en

Pulmonary pleomorphic carcinom ...... omplete response to nivolumab.

@nl

type

Item

label

Pulmonary pleomorphic carcinom ...... omplete response to nivolumab.

@en

Pulmonary pleomorphic carcinom ...... omplete response to nivolumab.

@nl

prefLabel

Pulmonary pleomorphic carcinom ...... omplete response to nivolumab.

@en

Pulmonary pleomorphic carcinom ...... omplete response to nivolumab.

@nl

P1476

Pulmonary pleomorphic carcinom ...... omplete response to nivolumab.

@en

P2093

Daiki Ogawara

http://www.w3.org/2001/XMLSchema#string

Hiroshi Mukae

http://www.w3.org/2001/XMLSchema#string

Kazuaki Okamura

http://www.w3.org/2001/XMLSchema#string

Keisuke Iwasaki

http://www.w3.org/2001/XMLSchema#string

Masataka Yoshida

http://www.w3.org/2001/XMLSchema#string

Shinichiro Fuchi

http://www.w3.org/2001/XMLSchema#string

Takayuki Suyama

http://www.w3.org/2001/XMLSchema#string

Tatsuhiko Harada

http://www.w3.org/2001/XMLSchema#string

Yuichi Fukuda

http://www.w3.org/2001/XMLSchema#string

P2860

PD-1 blockade induces responses by inhibiting adaptive immune resistance

In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates.

Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors.

Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan

Strength of PD-1 signaling differentially affects T-cell effector functions.

Expression of GARP Is Increased in Tumor-Infiltrating Regulatory T Cells and Is Correlated to Clinicopathology of Lung Cancer Patients

Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.

Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages.

High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma.

P304

193-196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1111/1759-7714.12557

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

H Soda

Minoru Fukuda

P577

2017-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29131510

http://www.w3.org/2001/XMLSchema#string

P932

5754285

http://www.w3.org/2001/XMLSchema#string

Pulmonary pleomorphic carcinoma with few PD-1-positive immune cells and regulatory T cells that showed a complete response to nivolumab.

about

P2860

P2860

Pulmonary pleomorphic carcinoma with few PD-1-positive immune cells and regulatory T cells that showed a complete response to nivolumab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932